Preclinical studies have shown promising results: Specific strains such as Bifidobacterium breve and Lactobacillus plantarum reduce microglial activation, increase anti-inflammatory cytokines like IL-10, promote neurogenesis, and enhance cognitive performance in rodent models of AD [624, 625]
D., Qu, H., Yang, Q
Medicaid coverage of GLP-1 receptor agonists for weight loss remains inconsistent nationwide, with approximately 40% of state programs covering these medications only for type 2 diabetes management rather than standalone weight reduction
When people are on these medications, all these beneficial things happen: Blood pressure gets better, cholesterol goes down, insulin resistance goes down, says the senior study author, Ziyad Al-Aly, MD, a clinical epidemiologist at WashU Medicine and the chief of the research and development service at the VA Saint Louis Health Care System, both in Missouri